Venus Medtech (Hangzhou) Inc. (HKG:2500)

Venus Medtech (Hangzhou) Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-714.31	-703.75	-1,058	-373.64
Depreciation & Amortization	66.47	76.67	108.36	48.76
Other Amortization	44.64	48.11	3.99	2.87
Loss (Gain) From Sale of Assets	-3.53	1.27	0.13	0.15
Asset Writedown & Restructuring Costs	187.99	248.78	420.23	236.15
Loss (Gain) From Sale of Investments	81.01	-21.29	0.19	0.66
Loss (Gain) on Equity Investments	4.15	12.38	13.94	11.71
Provision & Write-off of Bad Debts	21.44	-2.21	21.97	3.05
Other Operating Activities	26.29	-152.55	-98.26	-239.77
Change in Accounts Receivable	90.95	14.21	-7.85	-74.13
Change in Inventory	-0.59	-26.18	-13.68	-29.18
Change in Accounts Payable	4.85	24.73	0.38	3.46
Change in Unearned Revenue	-27.96	26.25	-12.92	0.29
Change in Other Net Operating Assets	242.35	-156.44	-108.26	-47.28
Operating Cash Flow	23.74	-610.02	-729.46	-456.92
Capital Expenditures	-33.92	-260.64	-169.98	-82.07
Sale of Property, Plant & Equipment	14.62	2.91	9.41	-
Cash Acquisitions	-	-	-813.49	-124.59
Divestitures	-0.48	-	-	22.5
Sale (Purchase) of Intangibles	-7.64	-2.27	-8.79	-19.71
Sale (Purchase) of Real Estate	-	-	-	-43.39
Investment in Securities	-	-18.77	-98.17	-416.78
Other Investing Activities	7.52	-68.09	4.76	15
Investing Cash Flow	-19.9	-346.86	-1,072	-653.04
Long-Term Debt Issued	104.03	413.48	939.14	-
Total Debt Issued	104.03	413.48	939.14	-
Long-Term Debt Repaid	-563.26	-543.81	-237.46	-20.25
Total Debt Repaid	-563.26	-543.81	-237.46	-20.25
Net Debt Issued (Repaid)	-459.23	-130.34	701.68	-20.25
Issuance of Common Stock	-	-	-	1,206
Repurchase of Common Stock	-	-	-	-72.55
Other Financing Activities	-28.11	-43.65	-66.55	278.31
Financing Cash Flow	-487.34	-173.99	635.14	1,391
Foreign Exchange Rate Adjustments	7.14	25.83	90.81	-34.4
Net Cash Flow	-476.36	-1,105	-1,076	247.04
Free Cash Flow	-10.18	-870.66	-899.44	-538.99
Free Cash Flow Margin	-2.16%	-177.19%	-221.28%	-129.61%
Free Cash Flow Per Share	-0.02	-1.99	-2.05	-1.23
Cash Interest Paid	28.61	61.69	43.81	1.96
Cash Income Tax Paid	0.95	3.44	3.07	8.65
Levered Free Cash Flow	155.46	-717.63	-559.42	-268.15
Unlevered Free Cash Flow	165.86	-678.43	-531.53	-266.96
Change in Working Capital	309.59	-117.43	-142.32	-146.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.